// App-Quantinova.ai

102 : Minimal residual disease (MRD) detection with circulating tumor DNA (ctDNA) from personalized assays in stage II-III colorectal cancer patients in a U.K. multicenter prospective study (TRACC).

Researchers

Presenter

  • Gayathri Anandappa

Principal Investigators

  • Ruwaida Begum

  • Annette Bryant

  • Shruti Sharma

  • Derrick Renner

  • Maria Aresu

  • Clare Peckitt

  • Himanshu Sethi

  • Andrew Feber

  • Vanessa Alice Potter

  • Marius Paraoan

  • Muti Abulafi

  • Nicol George

  • Graham Branagan

  • Sarah Duff

  • Nicholas West

  • Alexey Aleshin

  • Ian Chau

  • David Cunningham

Medical Centers

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Natera, inc., San Carlos, CA.

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Institute for Cancer Research, London, United Kingdom

  • University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

  • Wrightington, Wigan and Leigh NHS Trust, Wigan, United Kingdom

  • Neonatal Unit, Croydon University Hospital, London, United Kingdom

  • Southend Hospital, Westcliff on Sea, United Kingdom

  • Salisbury NHS Foundation Trust Hosp, Salisbury, United Kingdom

  • Epsom and St. Helier NHS Foundation Trust, Epsom, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Royal Marsden Hospital, Surrey, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • Microsatellite instability

  • Circulating DNA

  • Tumor mutational burden

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A